Product
MPA
2 clinical trials
3 indications
Indication
kidney transplantIndication
Liver Transplant RejectionIndication
Adverse Reaction to ImmunosuppressantsClinical trial
A 12-Month, Randomized, Open-Label, Phase IIA Study Evaluating the Safety and Efficacy of Siplizumab in Combination With Belatacept and MPA Compared to Standard of Care Immunosuppression in de Novo Renal Transplant Recipients (ASCEND)Status: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
Clinical Evaluation of the Long-term Benefit of Enteric-coated Mycophenolate (MPAs) After Liver TransplantationStatus: Recruiting, Estimated PCD: 2023-06-30